Bamboos Health Care Holdings Ltd (2293) AI Stock Analysis

• Market Cap: HK$221.35M
• Dividend Yield: 9.09%
• Average Volume (3M): 115.92K
• Price to Earnings (P/E): 9.3
• Beta (1Y): 0.06
• Revenue Growth: -22.12%
• EPS Growth: -28.95%
• Country: HK
• Employees: 75
• Sector: Healthcare
• Sector Strength: 54
• Industry: Medical - Care Facilities
• EPS (TTM): 0.06
• Shares Outstanding: 402,460,000
• 10 Day Avg. Volume: 111,745
• 30 Day Avg. Volume: 115,915
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Bamboos Health Care Holdings Ltd faces challenges with declining revenue, which impacts its growth prospects despite strong profitability and liquidity. Technical indicators show a bearish trend, but the stock's valuation remains attractive with a fair P/E ratio and a high dividend yield. The balance between robust financial fundamentals and technical weaknesses results in a moderate overall score.

Bamboos Health Care Holdings Ltd Business Overview & Revenue Model

Company Description

Bamboos Health Care Holdings Ltd (2293) is a Hong Kong-based company that operates in the healthcare sector. It primarily provides healthcare staffing solutions, including the recruitment and placement of nurses and other healthcare professionals. The company also offers training and development programs for healthcare workers to enhance their skills and meet industry standards.

How the Company Makes Money

Bamboos Health Care Holdings Ltd generates revenue primarily through its staffing services, where it earns fees by recruiting and placing healthcare professionals in various medical institutions and facilities. The company charges clients for these staffing services, which include both permanent placements and temporary staffing solutions. Additionally, Bamboos Health Care Holdings Ltd may generate income from its training and development programs, where healthcare professionals pay for courses and certifications to improve their skills and qualifications. Strategic partnerships with healthcare facilities and organizations also contribute to the company's revenue by ensuring a steady demand for its staffing services.

Bamboos Health Care Holdings Ltd Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
94.79M	127.81M	141.40M	110.80M	72.32M
	Gross Profit
84.72M	77.66M	91.33M	82.19M	38.73M
	EBIT
40.72M	59.86M	74.09M	73.18M	33.69M
	EBITDA
52.76M	71.06M	81.32M	78.05M	42.71M
	Net Income Common Stockholders
30.92M	46.92M	58.62M	61.02M	30.69M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
81.15M	103.97M	93.83M	106.17M	101.63M
	Total Assets
318.06M	346.83M	351.35M	240.84M	181.88M
	Total Debt
63.73M	68.24M	68.96M	3.31M	5.76M
	Net Debt
-17.42M	-25.03M	-17.31M	-53.34M	-95.87M
	Total Liabilities
99.74M	124.51M	140.75M	46.05M	28.61M
	Stockholders Equity
218.33M	222.32M	210.60M	194.79M	153.27M
Cash Flow		Free Cash Flow
35.75M	41.67M	100.37M	49.42M	42.90M
	Operating Cash Flow
36.57M	41.94M	116.11M	49.44M	45.52M
	Investing Cash Flow
-7.09M	6.92M	-111.63M	-71.38M	-29.71M
	Financing Cash Flow
-39.72M	-41.80M	25.15M	-23.04M	-32.87M

Bamboos Health Care Holdings Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.55
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2293, the sentiment is Negative. The current price of 0.55 is below the 20-day moving average (MA) of 0.56, below the 50-day MA of 0.59, and below the 200-day MA of 0.60, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 43.97 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2293.

Bamboos Health Care Holdings Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3613	68 Neutral	$7.17B	14.32	12.58%	6.51%	5.69%	-7.43%
6869	66 Neutral	$20.34B	13.77	6.68%	4.39%	0.24%	-31.74%
2138	66 Neutral	HK$758.54M	21.33	0.66%	1.56%	169.20%	―
1314	62 Neutral	HK$306.05M	7.82	8.01%	15.98%	-2.52%	45.64%
2293	61 Neutral	HK$221.35M	9.26	10.72%	9.09%	-22.12%	-28.95%
Sector *	52 Neutral	$5.21B	3.55	-41.91%	2.83%	15.12%	0.42%
3886	50 Neutral	HK$1.66B	―	-6.55%	0.49%	0.04%	-4.88%

Bamboos Health Care Holdings Ltd Corporate Events

Bamboos Health Care Holdings Faces Delay in Transaction Disclosure

Bamboos Health Care Holdings Ltd, a company incorporated in the Cayman Islands, announced a delay in the publication of a discloseable transaction related to the acquisition of shares in SPDR Gold Trust. The delay was due to internal control deficiencies and personnel changes, which resulted in a breach of the Listing Rules. The company failed to ensure proper handover procedures and training for new staff, impacting compliance with the rules regarding the calculation of size tests and transaction aggregation.

Bamboos Health Care Expands Investment in SPDR Gold Trust

Bamboos Health Care Holdings Ltd has announced the acquisition of 8,600 shares in the SPDR Gold Trust for approximately HK$19.97 million, bringing their total holdings to 20,565 shares. This acquisition, combined with previous purchases, constitutes a discloseable transaction under the Listing Rules, reflecting the company’s strategic investment in gold securities.

Bamboos Health Care Reports Decline in Interim Results, Declares Dividend

Bamboos Health Care Holdings Ltd reported a significant decline in its financial performance for the six months ended December 31, 2024. The company’s revenue decreased by 20.5% to HK$39.5 million, and profit before income tax dropped by 38.6% to HK$12.9 million compared to the same period in 2023. Despite the downturn, the Board declared an interim dividend of HK2.5 cents per share, reflecting a commitment to return value to shareholders.

Bamboos Health Care Announces Interim Dividend for 2024

Bamboos Health Care Holdings Ltd has announced an interim cash dividend of HKD 0.025 per share for the six months ending December 31, 2024. This announcement reflects the company’s financial health and commitment to returning value to its shareholders, with the dividend payment scheduled for March 21, 2025.